Menopause and Perimenopause - References

Citations

  1. Fritz MA, Speroff L (2011). Menopause and perimenopausal transition. In Clinical Gynecologic Endocrinology and Infertility, 8th ed., pp. 673-748. Philadelphia: Lippincott Williams and Wilkins.

  2. North American Menopause Society (2012). The 2012 hormone therapy position statement of the North American Menopause Society. Menopause, 19(3): 257-271. Also available online: http://www.menopause.org/PSht12.pdf.

  3. North American Menopause Society (2015). The North American Menopause Society statement on continuing use of systemic hormone therapy after age 65. Menopause, 22(7): 693. http://www.menopause.org/docs/default-source/2015/2015-nams-hormone-therapy-after-age-65.pdf. Accessed August 24, 2015.

  4. North American Menopause Society (2010). Estrogen and progestogen use in postmenopausal women: 2010 position statement of the North American Menopause Society. Menopause, 17(2): 242-255. Also available online: http://www.menopause.org/PSht10.pdf.

  5. Cedars MI, Evans M (2008). Menopause. In RS Gibbs et al., eds., Danforth's Obstetrics and Gynecology, 10th ed., pp. 725-741. Philadelphia: Lippincott Williams and Wilkins.

  6. Fritz MA, Speroff L (2011). Postmenopausal hormone therapy. In Clinical Gynecologic Endocrinology and Infertility, 8th ed., pp. 749-857. Philadelphia: Lippincott Williams and Wilkins.

  7. American College of Obstetricians and Gynecologists (2001, reaffirmed 2010). Use of botanicals for management of menopausal symptoms. ACOG Practice Bulletin No. 28. Obstetrics and Gynecology, 97(6, Suppl): 1-11.

Other Works Consulted

  • American Association of Clinical Endocrinologists Menopause Guidelines Revision Task Force (2006). American Association of Clinical Endocrinologists medical guidelines for clinical practice for the diagnosis and treatment of menopause. Endocrine Practice, 12(3): 315-337.

  • Daley A, et al. (2011). Exercise for vasomotor menopausal symptoms. Cochrane Database of Systematic Reviews (9).

  • Grady D, Barrett-Connor E (2012). Menopause. In L Goldman, A Shafer, eds., Goldman's Cecil Medicine, 24th ed., pp. 1565-1571. Philadelphia: Saunders.

  • Levis S, et al. (2011). Soy isoflavones in the prevention of menopausal bone loss and menopausal symptoms. Archives of Internal Medicine, 171(15): 1363-1369.

  • Manson JE, Bassuk SS (2012). The menopause transition and postmenopausal hormone therapy. In DL Longo et al., eds., Harrison's Principles of Internal Medicine, 18th ed., vol. 2, pp. 3040-3046. New York: McGraw-Hill.

  • Shifren JL, Schiff I (2007). Menopause. In JS Berek, ed., Berek and Novak's Gynecology, 14th ed., pp. 1323-1340. Philadelphia: Lippincott Williams and Wilkins.

  • U.S. Preventive Services Task Force 2012. Menopausal Hormone Therapy for the Primary Prevention of Chronic Conditions: U.S. Preventive Services Task Force Recommendation Statement. Available online: http://www.uspreventiveservicestaskforce.org/uspstf12/menohrt/menohrtfinalrs.pdf.

WebMD Medical Reference from Healthwise
This information is not intended to replace the advice of a doctor. Healthwise disclaims any liability for the decisions you make based on this information.© 1995-2015 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.